Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Pathogenesis of Atherosclerosis

Background:

• Atherosclerosis is a major cause of mortality in developed nations.
• Significant knowledge gaps persist in understanding atherosclerosis pathogenesis.
• The mTOR signaling pathway is a critical, yet incompletely understood, component of atherogenesis.

Purpose of the Study:

• To elucidate the role of the mTOR signaling pathway in atherosclerosis.
• To explore potential therapeutic strategies targeting the mTOR pathway for atherosclerosis treatment.

Main Methods:

• Review of current basic and clinical research on atherosclerosis.
• Analysis of the mTOR signaling pathway's involvement in atherogenesis.
• Evaluation of rapamycin-based therapeutic strategies in other diseases.

Main Results:

• The mTOR pathway is a key player in the development of atherosclerosis.
• New details regarding the mTOR pathway's function in atherogenesis are continually emerging.
• Rapamycin has demonstrated efficacy in treating various diseases, suggesting potential for atherosclerosis.

Conclusions:

• Targeting the mTOR pathway represents a promising therapeutic avenue for atherosclerosis.
• Further research into the mTOR pathway could lead to novel and effective atherosclerosis treatments.
• Understanding atherosclerosis at cellular and molecular levels is crucial for effective intervention.